LRRC47 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.298800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.752000E-01
Normal-vs-Stage2
4.774800E-01
Normal-vs-Stage3
9.753700E-02
Normal-vs-Stage4
4.906600E-01
Stage1-vs-Stage2
8.335600E-01
Stage1-vs-Stage3
8.280100E-02
Stage1-vs-Stage4
1.497450E-01
Stage2-vs-Stage3
7.765700E-02
Stage2-vs-Stage4
6.454100E-02
Stage3-vs-Stage4
4.636000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.151200E-01
Normal-vs-AfricanAmerican
6.488400E-01
Normal-vs-Asian
9.132200E-01
Caucasian-vs-AfricanAmerican
8.034400E-01
Caucasian-vs-Asian
3.798200E-01
AfricanAmerican-vs-Asian
7.842200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.562600E-01
Normal-vs-Female
7.018400E-01
Male-vs-Female
2.254400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.126800E-01
Normal-vs-Age(41-60Yrs)
8.053000E-01
Normal-vs-Age(61-80Yrs)
4.115400E-01
Normal-vs-Age(81-100Yrs)
4.618200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.828000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.696600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.313000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.178300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.096000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.992600E-01
Normal-vs-Daily Drinker
5.722600E-01
Normal-vs-Weekly Drinker
8.191200E-01
Normal-vs-Occasional Drinker
9.328400E-01
Normal-vs-Social Drinker
3.421000E-01
Non Drinker-vs-Daily Drinker
2.923800E-01
Non Drinker-vs-Weekly Drinker
3.835800E-01
Non Drinker-vs-Occasional Drinker
6.367900E-02
Non Drinker-vs-Social Drinker
6.437000E-01
Daily Drinker-vs-Weekly Drinker
8.896800E-01
Daily Drinker-vs-Occasional Drinker
2.666200E-01
Daily Drinker-vs-Social Drinker
5.528000E-01
Weekly Drinker-vs-Occasional Drinker
5.628400E-01
Weekly Drinker-vs-Social Drinker
6.358600E-01
Occasional Drinker-vs-Social Drinker
1.395990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.090600E-01
Normal-vs-Grade 2
8.098600E-01
Normal-vs-Grade 3
8.199400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.767200E-01
Grade 1-vs-Grade 3
7.880000E-01
Grade 1-vs-Grade 4
8.090600E-01
Grade 2-vs-Grade 3
6.487000E-01
Grade 2-vs-Grade 4
8.098600E-01
Grade 3-vs-Grade 4
8.199400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.464000E-01
Normal-vs-NonDiabetic
6.445000E-01
Diabetic-vs-NonDiabetic
2.263800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.361400E-01
Normal-vs-NoPancreatitis
5.922800E-01
Pancreatitis-vs-NoPancreatitis
8.767400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.719800E-01
Normal-vs-N1
5.290400E-01
N0-vs-N1
9.433400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.790800E-01
Normal-vs-TP53-NonMutant
5.824600E-01
TP53-Mutant-vs-TP53-NonMutant
1.981780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
